Organogenesis, Inc., a Canton-based regenerative medicine company, announced today that it has signed a memorandum of understanding with China’s National Tissue Engineering Center.
The center is a stem cell and regenerative medicine consortium, the company said.
Organogenesis said it formed the agreement with the center while visiting China as a delegate of a Massachusetts trade mission headed by Governor Deval L. Patrick.
The agreement includes the commercialization and exporting of existing Organogenesis technology, including its signature product, Apligraf, which Organogenesis describes as a "bio-active wound healing" product.
(By Chris Reidy, Globe staff)